Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
- 1 February 2016
- journal article
- review article
- Published by Elsevier BV in Annals of Oncology
- Vol. 27 (2), 225-232
- https://doi.org/10.1093/annonc/mdv560
Abstract
Immunoscore is a prognostic tool defined to quantify in situ immune cell infiltrates and appears highly promising as a supplement to the tumor-node-metastasis (TNM) classification of various tumors. In colorectal cancer, an international task force has initiated prospective multicenter studies aiming to implement TNM-Immunoscore (TNM-I) in a routine clinical setting. In breast cancer, recommendations for the evaluation of tumor-infiltrating lymphocytes (TILs) have been proposed by an international working group. Regardless of promising results, there are potential obstacles related to implementing TNM-I into the clinic. Diverse methods may be needed for different malignancies and even within each cancer entity. Nevertheless, a uniform approach across malignancies would be advantageous. In nonsmall-cell lung cancer (NSCLC), there are several previous reports indicating an apparent prognostic importance of TILs, but studies on TILs in a TNM-I setting are sparse and no general recommendations are made. However, recently published data is promising, evoking a realistic hope of a clinical useful NSCLC TNM-I. This review will focus on the TNM-I potential in NSCLC and propose strategies for clinical implementation of a TNM-I in resected NSCLC.Keywords
Funding Information
- Northern Norway Health Region Authority
- Northern Norway Health Region Authority
This publication has 32 references indexed in Scilit:
- Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung CancerClinical Cancer Research, 2015
- Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non–Small Cell Lung CancerClinical Cancer Research, 2015
- The Non–Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient OutcomeAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Years of life lost as a measure of cancer burden on a national level.British Journal of Cancer, 2014
- Cancer classification using the Immunoscore: a worldwide task forceJournal of Translational Medicine, 2012
- The immune contexture in human tumours: impact on clinical outcomeNature Reviews Cancer, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Non-small-cell lung cancerThe Lancet, 2011
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007